ES2047544T3 - Produccion en alta concentracion de somatomedina c humana. - Google Patents

Produccion en alta concentracion de somatomedina c humana.

Info

Publication number
ES2047544T3
ES2047544T3 ES88302994T ES88302994T ES2047544T3 ES 2047544 T3 ES2047544 T3 ES 2047544T3 ES 88302994 T ES88302994 T ES 88302994T ES 88302994 T ES88302994 T ES 88302994T ES 2047544 T3 ES2047544 T3 ES 2047544T3
Authority
ES
Spain
Prior art keywords
somatomedine
human
high concentration
concentration production
titer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88302994T
Other languages
English (en)
Inventor
Paula Myers-Keith
Wendy J Cain
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
International Minerals and Chemical Corp
Original Assignee
International Minerals and Chemical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by International Minerals and Chemical Corp filed Critical International Minerals and Chemical Corp
Application granted granted Critical
Publication of ES2047544T3 publication Critical patent/ES2047544T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

SE DESCRIBE UN PROCEDIMIENTO DE FERMENTACION DE ALTA CONCENTRACION EMPLEANDO CELULAS TRASNFORMADORAS DE ESCHERICHIA COLI PORTADORAS DE UN PLASMIDO QUE CONTIENE ADN CODIFICADOR DE SOMATOMEDINA C. EMPLEANDO EL METODO DE ESTA INVENCION SE HAN OBTENIDO CONCENTRACIONES DE 900-1000 MG/L QUE REPRESENTAN ALREDEDOR DEL DOBLE DE LOS OBTENIDO POR PROCEDIMIENTOS DE TIPO MAS ANTIGUO.
ES88302994T 1987-04-06 1988-04-05 Produccion en alta concentracion de somatomedina c humana. Expired - Lifetime ES2047544T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/034,847 US5104796A (en) 1987-04-06 1987-04-06 High titer production of human somatomedin c

Publications (1)

Publication Number Publication Date
ES2047544T3 true ES2047544T3 (es) 1994-03-01

Family

ID=21878973

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88302994T Expired - Lifetime ES2047544T3 (es) 1987-04-06 1988-04-05 Produccion en alta concentracion de somatomedina c humana.

Country Status (9)

Country Link
US (1) US5104796A (es)
EP (1) EP0286345B1 (es)
JP (1) JP2609462B2 (es)
KR (1) KR960011523B1 (es)
AT (1) ATE98654T1 (es)
AU (1) AU607986B2 (es)
DE (1) DE3886250T2 (es)
ES (1) ES2047544T3 (es)
NZ (1) NZ224113A (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5200509A (en) * 1987-04-06 1993-04-06 Celtrix Pharmaceuticals, Inc. Human somatomedin carrier protein subunits and process for producing them; recombinant DNA molecules, hosts, processes and human somatomedin carrier protein-like polypeptides
US5288931A (en) * 1991-12-06 1994-02-22 Genentech, Inc. Method for refolding insoluble, misfolded insulin-like growth factor-I into an active conformation
US5663304A (en) * 1993-08-20 1997-09-02 Genentech, Inc. Refolding of misfolded insulin-like growth factor-I
US5589364A (en) * 1994-07-29 1996-12-31 Magainin Pharmaceuticals Inc. Recombinant production of biologically active peptides and proteins
WO1996007744A1 (en) * 1994-09-08 1996-03-14 Chiron Corporation A method of improved production of insulin-like growth factor
US6475725B1 (en) 1997-06-20 2002-11-05 Baxter Aktiengesellschaft Recombinant cell clones having increased stability and methods of making and using the same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3926737A (en) * 1972-05-10 1975-12-16 New Brunswick Scientific Co Method and apparatus for control of biochemical processes
US4413305A (en) * 1982-06-21 1983-11-01 The Bendix Corporation Terminal for a capacitor and a method of forming same
BG49718A3 (en) * 1983-07-15 1992-01-15 Bio- Technology General Corp Method for preparing of polypeptid with superoxiddismutasne activitty
WO1985000831A1 (en) * 1983-08-10 1985-02-28 Amgen Microbial expression of insulin-like growth factor
US4788144A (en) * 1985-06-28 1988-11-29 International Minerals & Chemical Corp. Fermentation process for the high level production of swine growth
US4762784A (en) * 1985-07-15 1988-08-09 International Minerals & Chemical Corp. Fermemtation process for the high level production of bovine growth hormone
US4769361A (en) * 1986-08-07 1988-09-06 International Minerals & Chemical Corp. Method for purifying and isolating two ionic forms of somatomedin C

Also Published As

Publication number Publication date
AU1439388A (en) 1988-10-06
KR960011523B1 (ko) 1996-08-23
ATE98654T1 (de) 1994-01-15
DE3886250T2 (de) 1994-05-05
JP2609462B2 (ja) 1997-05-14
EP0286345A3 (en) 1989-10-04
AU607986B2 (en) 1991-03-21
JPS6420098A (en) 1989-01-24
NZ224113A (en) 1990-11-27
KR880012757A (ko) 1988-11-29
DE3886250D1 (de) 1994-01-27
EP0286345A2 (en) 1988-10-12
EP0286345B1 (en) 1993-12-15
US5104796A (en) 1992-04-14

Similar Documents

Publication Publication Date Title
PT95152A (pt) Processo de producao de factor neurotrofico derivado de cerebro (bdnf) dos meios para o mesmo e de composicoes farmaceuticas
BR8703269A (pt) Adn ou arn substancialmente puro;celulas contendo adn ou arn;processo para a expressao de eritropoietina humana recombinante biologicamente ativa;eritropoietina humana
PT87647A (pt) Process for the preparation of interchanging ions resins carried with quinolonocarboxylic acids derivatives and of veterinaries compounds for the treatment of mastitis which contain them
HUT52544A (en) Process for production of artery-system anticoagulant proteins and dns coding them
HUT42051A (en) Process for producing certain enanthiomere pairs of alpha-cyano-3-phenoxy-4-fluoro-benzyl-ester of permetrinic acid
EP0284577A3 (en) Process for production of chlorine dioxide
ES2047544T3 (es) Produccion en alta concentracion de somatomedina c humana.
EP0395706A4 (en) Production of gonorrheal pi proteins and vaccines
PT82116A (en) Process for production of chlorine dioxide
NZ216366A (en) Production of 7-amino-3-alkoxymethyl-3-cephem-4-carboxylic acid derivatives
HUT40113A (en) Process for production of insecticides containing derivatives of barbiture acid
AU664036B2 (en) Process for the production of activated sialic acids
AU586352B2 (en) Process for concentration of an aqueous solution of amino acid
EP0434393A3 (en) Process for preparation of r-(-)-3-halogeno-1,2-propanediol by treatment with microorganism
EP0187138A3 (en) Microorganism and plasmid for the constitutive synthesis of creatine amidino hydrolase and method for their production
GR3004118T3 (es)
ZA862240B (en) Production of human somatomedin c
DE3871519D1 (de) Verfahren zur inaktivierung rekombinanter dna.
ES2077707T3 (es) Procedimiento para la inactivacion de la actividad biologica de adn.
ES8705033A1 (es) Un metodo para preparar una vacuna para uso en el tratamiento prevencion de diarrea porcina neonatol.
FR2592060A1 (fr) Molecule de synthese de nature caseinique, riche en methionine et procede d'obtention a l'echelle de la production industrielle
HUT47262A (en) Process for production of derivatives of 2,1-benzotiazepin-2,2-dioxid-5-carbonic acid
PH22880A (en) Etodolac for treatment of gout
DE3780629D1 (es)
ATE13633T1 (de) Verfahren zur herstellung von hochgereinigtem antihaemophiliefaktor.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 286345

Country of ref document: ES